Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques
eLife · 22.02.2024 · 12
DOI: 10.7554/elife.89395 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 22.02.2024. Verfasst von Anil Verma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, United States. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV-1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIH Office of the Director.
Abstract (Originalsprache)
CD4 T follicular helper cells (T fh ) are essential for establishing serological memory and have distinct helper attributes that impact both the quantity and quality of the antibody response. Insights into T fh subsets that promote antibody persistence and functional capacity can critically inform vaccine design. Based on the T fh profiles evoked by the live attenuated measles virus vaccine, renowned for its ability to establish durable humoral immunity, we investigated the potential of a T fh 1/17 recall response during the boost phase to enhance persistence of HIV-1 Envelope (Env) antibodies in rhesus macaques. Using a DNA-prime encoding gp160 antigen and T fh polarizing cytokines (interferon protein-10 (IP-10) and interleukin-6 (IL-6)), followed by a gp140 protein boost formulated in a cationic liposome-based adjuvant (CAF01), we successfully generated germinal center (GC) T fh 1/17 cells. In contrast, a similar DNA-prime (including IP-10) followed by gp140 formulated with monophosphoryl lipid A (MPLA) +QS-21 adjuvant predominantly induced GC T fh 1 cells. While the generation of GC T fh 1/17 cells with CAF01 and GC T fh 1 cells with MPLA +QS-21 induced comparable peak Env antibodies, the latter group demonstrated significantly greater antibody concentrations at week 8 after final immunization which persisted up to 30 weeks (gp140 IgG ng/ml- MPLA; 5500; CAF01, 2155; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, United States.
- Graduate Group in Immunology, University of California, Davis, Davis, United States.
- California National Primate Research Center, University of California, Davis, Davis, United States.
- Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, United States.
- Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, United States.
- Bioinformatics Core, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, United States.
ORCID-Profile: Justin C Smith, Smita S Iyer
Förderung
- NIAID NIH HHS
- NIH HHS
- NIH Office of the Director
- National Institutes of Health
Zitieren
APA
Verma, A., Hawes, C. E., Elizaldi, S. R., Smith, J. C., Rajasundaram, D., Pedersen, G. K., Shen, X., Williams, L. D., Tomaras, G. D., Kozlowski, P. A., Amara, R. R., & Iyer, S. S. (2024). Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques. eLife, 12. https://doi.org/10.7554/elife.89395
Vancouver
Verma A, Hawes CE, Elizaldi SR, Smith JC, Rajasundaram D, Pedersen GK, et al. Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques. eLife. 2024;12. doi:10.7554/elife.89395
BibTeX
@article{Verma2024,
author = {Verma, Anil and Hawes, Chase E and Elizaldi, Sonny R and Smith, Justin C and Rajasundaram, Dhivyaa and Pedersen, Gabriel Kristian and Shen, Xiaoying and Williams, LaTonya D and Tomaras, Georgia D and Kozlowski, Pamela A and Amara, Rama R and Iyer, Smita S},
title = {Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques},
journal = {eLife},
year = {2024},
volume = {12},
doi = {10.7554/elife.89395}
}
EUVIMED